NUVATION BIO
Oncology Therapeutics

NUVATION BIO: Funding & valuation

NUVATION BIO has $275.3M paid in by investors, lenders and donors.

Financials

Funding rounds, investors and revenue on record.

$275.3MTotal raised
Venture - Series UnknownLatest round
1Rounds and grants
Money by yearUSD, rounds and grants
2019$275.3M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Money

NUVATION BIO has $275.3M paid in by investors, lenders and donors.

$275.3MPaid in
StagePaidSignedAnnouncedSourceFiledAnnouncedPress
Money in
Equity raised
Jun 2019 · Venture round
$275.3MPaid
People cost

NUVATION BIO filed a median H-1B wage of $203k in 2026.

$203kMedian H-1B wage, 20268 casesSource ↗
$158k–$370kH-1B wage range8 positions
Median H-1B wage by role, 2026scale to $370k
Director of Corporate Development · 2$250k
Senior Scientist · 2$171k
Associate Director of Business Development · 2$163k
Vice President, Clinical Operations · 1$370k
Director-Field Systems and Digital Enablement · 1$235k
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".